Management of respiratory disorders and the pharmacist's role: COPD

Johnson George, Jenifer Liang

Research output: Chapter in Book/Report/Conference proceedingEncyclopaedia / Dictionary EntryOtherpeer-review

Abstract

Chronic obstructive pulmonary disease (COPD) is a preventable and treatable chronic lung disease characterized by persistent respiratory symptoms and airflow limitation. It is caused mainly by chronic exposure to inhaled irritants, especially through tobacco smoking. COPD is projected to be the 3rd leading cause of death by 2020. More than 3 million people died of COPD in 2012 accounting for 6% of all deaths globally. Exacerbations are a major cause of morbidity and mortality in patients with COPD, with adverse effects on quality of life and lung function. Pharmacists have a key role to play in the prevention, diagnosis, and management of the disease and symptoms. Short-acting and long-acting bronchodilators (beta agonists, muscarinic antagonists) alone or in combination, antiinflammatory agents (oral and inhaled corticosteroids), mucolytics and antibiotics (as required) are central to COPD management. Vaccination (influenza and pneumococcal), pulmonary rehabilitation and patient self-management guided by action plans may reduce the burden of COPD. Pharmacists can be actively involved in delivering smoking cessation interventions, case-finding of COPD (i.e., screening of high risk people with symptoms) using symptom questionnaires and handheld devices, and rationalize COPD management in both primary and secondary care settings by optimizing medicine use by both prescribers and patients.
Original languageEnglish
Title of host publicationThe Encyclopaedia of Pharmacy Practice and Clinical Pharmacy
EditorsZaheer-Ud-Din Babar
Place of PublicationSan Diego
PublisherElsevier Science Publishing Co Inc
Chapter509
Pages264-281
Number of pages18
Edition1st
ISBN (Electronic)9780128127360
ISBN (Print)9780128127353
DOIs
Publication statusPublished - 20 Jun 2019

Keywords

  • Bronchodilator
  • Chronic obstructive pulmonary disease
  • COPD
  • Dyspnea
  • Exacerbation
  • Inflammation
  • Mucus hypersecretion
  • Pharmacist
  • Pharmacy
  • Public health
  • Pulmonary rehabilitation
  • Self-management
  • Smoking
  • Spirometry

Cite this

George, J., & Liang, J. (2019). Management of respiratory disorders and the pharmacist's role: COPD. In Z-U-D. Babar (Ed.), The Encyclopaedia of Pharmacy Practice and Clinical Pharmacy (1st ed., pp. 264-281). San Diego: Elsevier Science Publishing Co Inc. https://doi.org/10.1016/B978-0-12-812735-3.00509-4
George, Johnson ; Liang, Jenifer. / Management of respiratory disorders and the pharmacist's role : COPD. The Encyclopaedia of Pharmacy Practice and Clinical Pharmacy. editor / Zaheer-Ud-Din Babar. 1st. ed. San Diego : Elsevier Science Publishing Co Inc, 2019. pp. 264-281
@inbook{bbdeb08daf5d4effb508e94bdf440344,
title = "Management of respiratory disorders and the pharmacist's role: COPD",
abstract = "Chronic obstructive pulmonary disease (COPD) is a preventable and treatable chronic lung disease characterized by persistent respiratory symptoms and airflow limitation. It is caused mainly by chronic exposure to inhaled irritants, especially through tobacco smoking. COPD is projected to be the 3rd leading cause of death by 2020. More than 3 million people died of COPD in 2012 accounting for 6{\%} of all deaths globally. Exacerbations are a major cause of morbidity and mortality in patients with COPD, with adverse effects on quality of life and lung function. Pharmacists have a key role to play in the prevention, diagnosis, and management of the disease and symptoms. Short-acting and long-acting bronchodilators (beta agonists, muscarinic antagonists) alone or in combination, antiinflammatory agents (oral and inhaled corticosteroids), mucolytics and antibiotics (as required) are central to COPD management. Vaccination (influenza and pneumococcal), pulmonary rehabilitation and patient self-management guided by action plans may reduce the burden of COPD. Pharmacists can be actively involved in delivering smoking cessation interventions, case-finding of COPD (i.e., screening of high risk people with symptoms) using symptom questionnaires and handheld devices, and rationalize COPD management in both primary and secondary care settings by optimizing medicine use by both prescribers and patients.",
keywords = "Bronchodilator, Chronic obstructive pulmonary disease, COPD, Dyspnea, Exacerbation, Inflammation, Mucus hypersecretion, Pharmacist, Pharmacy, Public health, Pulmonary rehabilitation, Self-management, Smoking, Spirometry",
author = "Johnson George and Jenifer Liang",
year = "2019",
month = "6",
day = "20",
doi = "10.1016/B978-0-12-812735-3.00509-4",
language = "English",
isbn = "9780128127353",
pages = "264--281",
editor = "Zaheer-Ud-Din Babar",
booktitle = "The Encyclopaedia of Pharmacy Practice and Clinical Pharmacy",
publisher = "Elsevier Science Publishing Co Inc",
edition = "1st",

}

George, J & Liang, J 2019, Management of respiratory disorders and the pharmacist's role: COPD. in Z-U-D Babar (ed.), The Encyclopaedia of Pharmacy Practice and Clinical Pharmacy. 1st edn, Elsevier Science Publishing Co Inc, San Diego, pp. 264-281. https://doi.org/10.1016/B978-0-12-812735-3.00509-4

Management of respiratory disorders and the pharmacist's role : COPD. / George, Johnson; Liang, Jenifer.

The Encyclopaedia of Pharmacy Practice and Clinical Pharmacy. ed. / Zaheer-Ud-Din Babar. 1st. ed. San Diego : Elsevier Science Publishing Co Inc, 2019. p. 264-281.

Research output: Chapter in Book/Report/Conference proceedingEncyclopaedia / Dictionary EntryOtherpeer-review

TY - CHAP

T1 - Management of respiratory disorders and the pharmacist's role

T2 - COPD

AU - George, Johnson

AU - Liang, Jenifer

PY - 2019/6/20

Y1 - 2019/6/20

N2 - Chronic obstructive pulmonary disease (COPD) is a preventable and treatable chronic lung disease characterized by persistent respiratory symptoms and airflow limitation. It is caused mainly by chronic exposure to inhaled irritants, especially through tobacco smoking. COPD is projected to be the 3rd leading cause of death by 2020. More than 3 million people died of COPD in 2012 accounting for 6% of all deaths globally. Exacerbations are a major cause of morbidity and mortality in patients with COPD, with adverse effects on quality of life and lung function. Pharmacists have a key role to play in the prevention, diagnosis, and management of the disease and symptoms. Short-acting and long-acting bronchodilators (beta agonists, muscarinic antagonists) alone or in combination, antiinflammatory agents (oral and inhaled corticosteroids), mucolytics and antibiotics (as required) are central to COPD management. Vaccination (influenza and pneumococcal), pulmonary rehabilitation and patient self-management guided by action plans may reduce the burden of COPD. Pharmacists can be actively involved in delivering smoking cessation interventions, case-finding of COPD (i.e., screening of high risk people with symptoms) using symptom questionnaires and handheld devices, and rationalize COPD management in both primary and secondary care settings by optimizing medicine use by both prescribers and patients.

AB - Chronic obstructive pulmonary disease (COPD) is a preventable and treatable chronic lung disease characterized by persistent respiratory symptoms and airflow limitation. It is caused mainly by chronic exposure to inhaled irritants, especially through tobacco smoking. COPD is projected to be the 3rd leading cause of death by 2020. More than 3 million people died of COPD in 2012 accounting for 6% of all deaths globally. Exacerbations are a major cause of morbidity and mortality in patients with COPD, with adverse effects on quality of life and lung function. Pharmacists have a key role to play in the prevention, diagnosis, and management of the disease and symptoms. Short-acting and long-acting bronchodilators (beta agonists, muscarinic antagonists) alone or in combination, antiinflammatory agents (oral and inhaled corticosteroids), mucolytics and antibiotics (as required) are central to COPD management. Vaccination (influenza and pneumococcal), pulmonary rehabilitation and patient self-management guided by action plans may reduce the burden of COPD. Pharmacists can be actively involved in delivering smoking cessation interventions, case-finding of COPD (i.e., screening of high risk people with symptoms) using symptom questionnaires and handheld devices, and rationalize COPD management in both primary and secondary care settings by optimizing medicine use by both prescribers and patients.

KW - Bronchodilator

KW - Chronic obstructive pulmonary disease

KW - COPD

KW - Dyspnea

KW - Exacerbation

KW - Inflammation

KW - Mucus hypersecretion

KW - Pharmacist

KW - Pharmacy

KW - Public health

KW - Pulmonary rehabilitation

KW - Self-management

KW - Smoking

KW - Spirometry

U2 - 10.1016/B978-0-12-812735-3.00509-4

DO - 10.1016/B978-0-12-812735-3.00509-4

M3 - Encyclopaedia / Dictionary Entry

SN - 9780128127353

SP - 264

EP - 281

BT - The Encyclopaedia of Pharmacy Practice and Clinical Pharmacy

A2 - Babar, Zaheer-Ud-Din

PB - Elsevier Science Publishing Co Inc

CY - San Diego

ER -

George J, Liang J. Management of respiratory disorders and the pharmacist's role: COPD. In Babar Z-U-D, editor, The Encyclopaedia of Pharmacy Practice and Clinical Pharmacy. 1st ed. San Diego: Elsevier Science Publishing Co Inc. 2019. p. 264-281 https://doi.org/10.1016/B978-0-12-812735-3.00509-4